Home > News > Starpharma Continues to Look Good
March 5th, 2006
Starpharma Continues to Look Good
Abstract:
Jack Uldrich: Since my book went to press, two developments have occurred that have served to heighten my optimism about Starpharma’s long-term potential. The first occurred in December when the U.S government granted the Australian company a $20 million grant to expediate its FDA (Food and Drug Administration) approval process for a nanotechnology-based treatment designed to prevent HIV and genital herpes.
Source:
NanoNovus
Bookmark:
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Nanomedicine
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013